Clinical Trials for ExpreS2ion Biotechnologies

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ExpreS2ion Biotechnologies

Clinical Trials (1)

NCT06746688
A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2 Expressing Metastatic Breast Cancer.
PHASE1Recruiting
27 participants
Started: Jun 3, 2025 · Completed: Mar 31, 2026
2 conditions4 sponsors1 location